第一单位:
Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.
作者:
Maike,Janssen [1]
;
Christina,Schmidt [2]
;
Peter-Martin,Bruch [1]
;
Maximilian F,Blank [3]
;
Christian,Rohde [1]
;
Alexander,Waclawiczek [4]
;
Daniel,Heid [1]
;
Simon,Renders [5]
;
Stefanie,Göllner [2]
;
Lisa,Vierbaum [2]
;
Birgit,Besenbeck [2]
;
Sophie A,Herbst [1]
;
Mareike,Knoll [2]
;
Carolin,Kolb [2]
;
Adriana,Przybylla [4]
;
Katharina,Weidenauer [2]
;
Anne Kathrin,Ludwig [1]
;
Margarete,Fabre [6]
;
Muxin,Gu [6]
;
Richard F,Schlenk [2]
;
Friedrich,Stölzel [7]
;
Martin,Bornhäuser [7]
;
Christoph,Röllig [7]
;
Uwe,Platzbecker [8]
;
Claudia,Baldus [9]
;
Hubert,Serve [10]
;
Tim,Sauer [2]
;
Simon,Raffel [2]
;
Caroline,Pabst [1]
;
George,Vassiliou [6]
;
Binje,Vick [11]
;
Irmela,Jeremias [12]
;
Andreas,Trumpp [4]
;
Jeroen,Krijgsveld [13]
;
Carsten,Müller-Tidow [1]
;
Sascha,Dietrich [1]
作者单位:
Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.
[1]
Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
[2]
Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.;Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany.
[3]
Division of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany.
[4]
Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.;Division of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany.
[5]
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.;Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.;Department of Hematology, University of Cambridge, Cambridge, United Kingdom.
[6]
Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[7]
Medical Clinic and Policlinic I, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany.
[8]
Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
[9]
Hematology-Oncology, Department of Medicine II, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany.
[10]
Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.;German Cancer Consortium, Partner Site Munich, Munich, Germany.
[11]
Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.;German Cancer Consortium, Partner Site Munich, Munich, Germany.;Department of Pediatrics, University Hospital, Ludwig Maximilian University, Munich, Germany.
[12]
Division of Proteomics of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany.;Medical Faculty, Heidelberg University, Heidelberg, Germany.
[13]
DOI
10.1182/blood.2021014241
PMID
35857899
发布时间
2025-05-30